Open Access
Systematic Review
Issue
J Oral Med Oral Surg
Volume 28, Number 1, 2022
Article Number 8
Number of page(s) 9
DOI https://doi.org/10.1051/mbcb/2021052
Published online 21 February 2022
  1. Rai A, Siddiqui M, Parveen S, Parveen S, Rasheed A, Ali S. Molecular pathogenesis of oral submucous fibrosis: a critical appraisal. Biomed Pharmacol J 2019;12:2027–2036. [CrossRef] [Google Scholar]
  2. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966;22:764–779. [Google Scholar]
  3. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36:575–580. [CrossRef] [PubMed] [Google Scholar]
  4. More CB, Rao NR. Proposed clinical definition for oral submucous fibrosis. J Oral Biol Craniofac Res 2019;9:311–314. [CrossRef] [PubMed] [Google Scholar]
  5. Khan S, Sinha A, Kumar S, Iqbal H. Oral submucous fibrosis: current concepts on aetiology and management − a review. J Indian Acad Oral Med Radiol 2018;30:407–407. [CrossRef] [Google Scholar]
  6. Rao NR, Villa A, More CB, Jayasinghe RD, Kerr AR, Johnson NW. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg 2020;49:3. [CrossRef] [PubMed] [Google Scholar]
  7. Chattopadhyay A, Ray JG. Molecular Pathology of malignant transformation of oral submucous fibrosis. JEP(T) 2016;35. Available from: http://www.dl.begellhouse.com/journals/0ff459a57a4c08d0,2d1506ed13a32809,0c3016997dd60aeb.html [Google Scholar]
  8. Arakeri G, Patil SG, Aljabab AS, Lin K-C, Merkx MaW, Gao S, et al. Oral submucous fibrosis: an update on pathophysiology of malignant transformation. J Oral Pathol Med 2017;46:413–417. [CrossRef] [PubMed] [Google Scholar]
  9. Srivastava R, Jyoti B, Pradhan D, Siddiqui Z. Prevalence of oral submucous fibrosis in patients visiting dental OPD of a dental college in Kanpur: a demographic study. J Family Med Prim Care 2019;8:2612–2617. [CrossRef] [PubMed] [Google Scholar]
  10. Teh MT, Tilakaratne WM, Chaplin T, Young BD, Ariyawardana A, Pitiyage G, et al. Fingerprinting genomic instability in oral submucous fibrosis. J Oral Pathol Med 2008;37:430–436. [CrossRef] [PubMed] [Google Scholar]
  11. More CB, Jatti Patil D, Rao NR. Medicinal management of oral submucous fibrosis in the past decade − a systematic review. J Oral Biol Craniofac Res 2020;10:552–568. [CrossRef] [PubMed] [Google Scholar]
  12. Fedorowicz Z, Chan Shih-Yen E, Dorri M, Nasser M, Newton T, Shi L. Interventions for the management of oral submucous fibrosis. Cochrane Database Syst Rev 2008;CD007156. [PubMed] [Google Scholar]
  13. de la Jara A, Ruano-Rodriguez C, Polifrone M, Assunçao P, Brito-Casillas Y, Wägner AM, et al. Impact of dietary Arthrospira (Spirulina) biomass consumption on human health: main health targets and systematic review. J Appl Phycol 2018;30:2403–2423. [CrossRef] [Google Scholar]
  14. Hamedifard Z, Milajerdi A, Reiner Ž, Taghizadeh M, Kolahdooz F, Asemi Z. The effects of spirulina on glycemic control and serum lipoproteins in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Phytother Res 2019;33:2609–2621. [CrossRef] [PubMed] [Google Scholar]
  15. Hatami E, Ghalishourani S-S, Najafgholizadeh A, Pourmasoumi M, Hadi A, Clark CCT, et al. The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord 2021. Available from: https://doi.org/10.1007/s40200-021-00760-z [PubMed] [Google Scholar]
  16. Finamore A, Palmery M, Bensehaila S, Peluso I. Antioxidant, immunomodulating, and microbial-modulating activities of the sustainable and ecofriendly spirulina. Oxidat Med Cell Longev 2017;2017:3247528. [CrossRef] [Google Scholar]
  17. Ravi M, De SL, Azharuddin S, Paul SF. The beneficial effects of Spirulina focusing on its immunomodulatory and antioxidant properties. Nutr Diet Suppl 2010;2:73–83. [Google Scholar]
  18. Deng R, Chow T-J. Hypolipidemic, antioxidant and antiinflammatory activities of microalgae spirulina. Cardiovasc Ther 2010;28:e33–45. [CrossRef] [PubMed] [Google Scholar]
  19. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. [CrossRef] [PubMed] [Google Scholar]
  20. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020;368:l6890. [CrossRef] [PubMed] [Google Scholar]
  21. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366. Available from: https://www.bmj.com/content/366/bmj.l4898 [Google Scholar]
  22. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355. Available from: https://www.bmj.com/content/355/bmj.i4919 [Google Scholar]
  23. Mulk BS, Deshpande P, Velpula N, Chappidi V, Chintamaneni RL, Goyal S. Spirulina and pentoxyfilline–A novel approach for treatment of oral submucous fibrosis. Journal of clinical and diagnostic research: JCDR 2013;7:3048. [Google Scholar]
  24. Patil S, Khandelwal S, Maheshwari S. Comparative efficacy of newer antioxidants spirulina and lycopene for the treatment of oral submucous fibrosis. Clin Cancer Invest J 2014;3:482. [CrossRef] [Google Scholar]
  25. Patil S, Al-Zarea BK, Maheshwari S, Sahu R. Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. J Oral Biol Craniof Res. 2015;5:11–5. [CrossRef] [Google Scholar]
  26. Patil SR, Maragathavalli G, Ramesh D, Munishekar MS, Rao KA, Alam MK. Comparative efficacy of newer antioxidants spirulina and oxitard for the treatment of oral submucous fibrosis. Int Med J 2019;26. [Google Scholar]
  27. Shetty P, Shenai P, Chatra L, Rao P. Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis. Indian J Dental Res 2013;24:347–350. [CrossRef] [PubMed] [Google Scholar]
  28. Jain A, Taneja S. Oral submucous fibrosis in pediatric patients: a systematic review and protocol for management. Int J Surg Oncol 2019;2019. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463605/ [Google Scholar]
  29. Shah B, Lewis MA, Bedi R. Oral submucous fibrosis in a 11-year-old Bangladeshi girl living in the United Kingdom. Br Dent J 2001;191:130–132. [CrossRef] [PubMed] [Google Scholar]
  30. Hayes PA. Oral submucous fibrosis in a 4-year-old girl. Oral Surg Oral Med Oral Pathol 1985;59:475–478. [Google Scholar]
  31. Mahmoud YI, Shehata AMM, Fares NH, Mahmoud AA. Spirulina inhibits hepatocellular carcinoma through activating p53 and apoptosis and suppressing oxidative stress and angiogenesis. Life Sciences 2021;265:118827. [CrossRef] [PubMed] [Google Scholar]
  32. Najem AM, Abed IJ, Fadhel LZ. Assessment the activity of spirulina platensis alcoholic extract in MCF-7 breast cancer cells inhibition and P-53 gene induction. Public Health 8. [Google Scholar]
  33. Serban M-C., Sahebkar A, Dragan S, Stoichescu-Hogea G, Ursoniu S, Andrica F, et al. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clin Nutr 2016;35:842–851. [CrossRef] [PubMed] [Google Scholar]
  34. Moradi S, Ziaei R, Foshati S, Mohammadi H, Nachvak SM, Rouhani MH. Effects of Spirulina supplementation on obesity: a systematic review and meta-analysis of randomized clinical trials. Complement Ther Med 2019;47:102211. [CrossRef] [PubMed] [Google Scholar]
  35. Mahendra J, Mahendra L, Muthu J, John L, Romanos GE. Clinical effects of subgingivally delivered spirulina gel in chronic periodontitis cases: a placebo controlled clinical trial. J Clin Diagn Res 2013;7:2330–2333. [PubMed] [Google Scholar]
  36. Maniyar R. Effectiveness of spirulina mouthwash on reduction of dental plaque and gingivitis: a clinical study. Int J Pharm Pharmaceut Sci 2017;9:136. [CrossRef] [Google Scholar]
  37. Mathew B, Sankaranarayanan R, Nair P, Varghese C, Somanathan T, Amma B, et al. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr Cancer 1995;24:197–202. [CrossRef] [PubMed] [Google Scholar]
  38. Karkos PD, Leong SC, Karkos CD, Sivaji N, Assimakopoulos DA. Spirulina in clinical practice: evidence-based human applications. Evidence-Based Complemen Alternat Med 2010;2011:enen058. [Google Scholar]
  39. Schwartz J, Shklar G, Reid S, Trickier D. Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae. Nutr Cancer 1988;11:127–34. [CrossRef] [PubMed] [Google Scholar]
  40. Shklar G, Schwartz J. Tumor necrosis factor in experimental cancer regression with alphatocopherol, beta-carotene, canthaxanthin and algae extract. Eur J Cancer Clin Oncol 1988;24:839–850. [CrossRef] [PubMed] [Google Scholar]
  41. Schwartz J, Shklar G. Regression of experimental hamster cancer by beta carotene and algae extracts. J Oral Maxillofac Surg 1987;45:510–515. [CrossRef] [PubMed] [Google Scholar]
  42. Gupta N, Kalaskar A, Kalaskar R. Efficacy of lycopene in management of oral submucous fibrosis − a systematic review and meta-analysis. J Oral Biol Craniofac Res 2020;10:690–697. [CrossRef] [PubMed] [Google Scholar]
  43. Al-Maweri SA, Ashraf S, Lingam AS, Alqutaibi A, Abdulrab S, Alaizari N, et al. Aloe vera in treatment of oral submucous fibrosis: a systematic review and meta-analysis. J Oral Pathol Med 2019;48:99–107. [CrossRef] [PubMed] [Google Scholar]
  44. Liu J, Chen F, Wei Z, Qiu M, Li Z, Hongxia D, et al. Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: a meta-analysis. Oral Diseases 2017;24. [Google Scholar]
  45. Marles RJ, Barrett ML, Barnes J, Chavez ML, Gardiner P, Ko R, et al. United States pharmacopeia safety evaluation of spirulina. Crit Rev Food Sci Nutr 2011;51:593–604. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.